查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1806346

生物樣本庫市場按類型、組件、樣本類型、應用和最終用戶分類－2025-2030 年全球預測

Biobanks Market by Type, Component, Sample Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年生物銀行市場價值將達到1,154.3億美元，2025年成長至1,305.6億美元，複合年成長率為13.49%，到2030年將達到2,467.2億美元。

主要市場統計數據
基準年2024年 1154.3億美元
預計2025年 1305.6億美元
預測年份 2030 2467.2億美元
複合年成長率（%） 13.49%

揭示現代生物庫在塑造生物醫學研究和醫療保健創新未來的重要基礎和策略重要性

現代生物樣本庫是支持轉化研究、個人化醫療和治療創新發展的基礎支柱。透過系統地收集、處理、儲存和分發高品質的生物檢體，這些樣本庫彌合了發現科學與臨床應用之間的差距。此外，強大的資料管理系統與實體檢體庫的整合，使生物樣本庫從單純的儲存設施提升為充滿活力的研究推動者，促進了學術界、產業界和醫療機構之間的合作。

探索透過技術進步、數據整合和協作生態系統改變生物庫營運的重大模式轉移

由於技術突破和合作模式的轉變，生物樣本庫的模式正在發生巨大變化。高通量基因組定序平台如今能夠同時快速分析數千個樣本，從而為疾病機制和患者分層提供新的見解。同時，人工智慧和機器學習演算法的引入正在徹底改變資料管理和模式識別，以前所未有的速度推動預測分析和生物標記發現。

評估美國2025年關稅政策對生物庫供應鏈的深遠影響：創新成本與全球合作

美國2025年關稅法案的實施為依賴複雜全球供應鏈的生物樣本庫營運帶來了複雜的挑戰。實驗室耗材、低溫儲存系統和敏感設備的關稅上調，推高了成本，並導致採購延誤。因此，生物樣本庫管理人員正在審查供應商契約，探索替代籌資策略，並探索近岸外包機會，以減輕進口關稅上漲的影響。

分析關鍵細分維度、各種生物庫類型、元件、樣本類型、應用程式和最終用戶動態，揭示市場動態

由於生物樣本庫服務於多元化的研究、臨床和商業終端用戶，因此對市場區隔的細緻理解是製定精準策略的基礎。以疾病為導向的模型專注於與特定病理相關的檢體，為腫瘤學、心臟病學和神經病學研究提供客製化的資源。相反，基於基因組的樣本庫管理DNA和RNA萃取物，以支持群體基因組學和變異發現；而基於人群的樣本庫則收集不同人口群體的樣本，以支持流行病學研究。虛擬生物樣本庫將元資料記錄整合到可存取的數位圖書館中，有效地實現了無需實際出行即可發現樣本的民主化。

了解美洲、歐洲、中東和非洲以及亞太地區的生物銀行生態系統的區域動態和戰略機會

由於地緣政治因素、資金籌措狀況和監管環境因地區而異，區域動態顯著影響生物樣本庫計畫的戰略軌跡。在美洲，強勁的公共和私人投資培育了一個成熟的生態系統，其特點是成熟的樣本庫與領先的學術醫療中心和創新的生物技術叢集相結合。監管監督確保了患者知情同意和資料隱私標準，而北美和南美的跨境合作則促進了大規模隊列研究的進行。

確定產業領導者；策略聯盟和競爭優勢將塑造生物銀行市場格局的未來發展軌跡

生物樣本庫領域的領先公司正透過策略合作夥伴關係、技術創新和不斷擴展的服務組合來脫穎而出。領先的生命科學公司利用全球分銷網路，提供整合樣本管理軟體、低溫運輸物流和可客製化分析工作流程的承包生物樣本庫解決方案；而專業服務供應商與學術醫療中心合作，共同開發以疾病為重點的樣本庫，以加速轉化研究成果的轉化。

生物樣本庫領導者的策略必要事項：因應複雜的監管環境；擁抱創新，加強全球夥伴關係，實現持續成長

為了在技術創新快速、監管複雜的時代取得成功，生物樣本庫領導者必須制定兼顧敏捷性和管治的策略藍圖。優先投資數位基礎設施，可以即時追蹤樣本來源、實現自動化品管檢查，並與外部資料來源無縫整合。同時，透過多供應商採購和區域夥伴關係實現供應鏈多元化，可以降低貿易政策和物流中斷帶來的風險。

嚴謹的研究框架，協助提供全面的生物樣本庫市場情報。了解更多關於我們的資料收集方法和分析方法。

這項全面分析背後的調查方法融合了多種資料收集和分析手段，以確保研究的深度和可靠性。主要見解是透過與領先生物樣本庫的高階主管、科學總監和採購經理進行結構化訪談收集的。這些第一手觀點提供了營運挑戰、技術應用趨勢和策略重點的背景資訊。

綜合關鍵見解和策略要點，幫助決策者引導生物庫舉措走向長期成功和影響

摘要，生物樣本庫已成為生物醫學研究和醫療保健創新體系中具有策略意義的重要部分。基因組學、數據分析和數位整合領域的技術進步正在重塑營運模式，而關稅政策和供應鏈考量也帶來了新的複雜性，需要積極主動的管理。詳細的細分洞察揭示了對疾病導向、基於基因組、人群和虛擬樣本庫的多樣化需求，每種需求都由專門的組件和服務提供支援。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 個人化醫療需求的不斷成長推動了全球生物銀行設施的擴張
  • 整合人工智慧和巨量資料分析，改進生物樣本庫處理
  • 增加政府津貼和資助舉措，加強生物銀行研究能力
  • 擴大大規模基於人群和針對特異性疾病的生物庫，用於多樣化的醫學研究
  • 引進自動化儲存和檢索技術，提高生物庫營運效率
  • 冷凍保存技術的進步提高了生物檢體的長期品質和穩定性
  • 透過生物庫和製藥公司之間的策略夥伴關係和合作加速藥物發現
  • 解決影響現代生物庫管治架構的倫理挑戰與資料隱私問題
  • 生物樣本庫在罕見和複雜疾病研究中的重要性日益增強，有助於提供更好的診斷解決方案
  • 商業生物樣本庫的出現，為全球研究提供了高品質的生物樣本

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章：2025年美國關稅的累積影響

第 8 章 生物樣本庫市場（按類型）

  • 以疾病為導向的生物庫
  • 基於基因組的生物庫
  • 基於人群的生物樣本庫
  • 虛擬生物庫

第9章生物樣本庫市場（按組成部分）

  • 耗材
  • 裝置
    • 培養箱和離心機
    • 監控系統
    • 溫度控制系統
      • 低溫儲存系統
      • 冷凍庫和冰箱
      • 解凍裝置
  • 服務
    • 資料管理
    • 樣品分析
    • 儲存和處理
    • 運輸

第 10 章。生物樣本庫市場（按樣本類型）

  • 血液製品
  • 細胞株
  • 核酸
  • 組織

第 11 章 生物樣本庫市場（按應用）

  • 臨床診斷
  • 個人化醫療
  • 調查
  • 治療藥物
    • 藥物開發
    • 基因編輯

第 12 章 生物樣本庫市場（按最終用戶分類）

  • 學術機構
  • 生技公司
  • 醫院
  • 製藥公司

第 13 章：美洲生物銀行市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲生物銀行市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太生物庫市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • ASKION GmbH
    • Avantor, Inc.
    • Bay Biosciences LLC
    • Beckman Coulter, Inc. by Danaher Corporation
    • Becton, Dickinson and Company
    • BioIVT LLC
    • BioKryo by L'AIR LIQUIDE SA
    • BioLife Solutions Inc.
    • BocaBio
    • Charles River Laboratories International, Inc.
    • Cryoport Systems, LLC
    • CTIBiotech
    • Cureline, Inc.
    • Firalis Group
    • Greiner AG
    • Hamilton Company
    • LVL Technologies GmbH & Co. KG
    • Merck KGaA
    • Micronic Holding BV
    • ProteoGenex, Inc.
    • Provia Laboratories, LLC
    • Qiagen NV
    • Shanghai Outdo Biotech Co. Ltd
    • Taylor-Wharton
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • UK Biobank Limited

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-437D4595886E

The Biobanks Market was valued at USD 115.43 billion in 2024 and is projected to grow to USD 130.56 billion in 2025, with a CAGR of 13.49%, reaching USD 246.72 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 115.43 billion
Estimated Year [2025] USD 130.56 billion
Forecast Year [2030] USD 246.72 billion
CAGR (%) 13.49%

Unveiling the Pivotal Foundations and Strategic Importance of Modern Biobanks in Shaping the Future of Biomedical Research and Healthcare Innovations

Modern biobanks serve as foundational pillars underpinning the advancement of translational research, personalized medicine, and therapeutic innovation. By systematically collecting, processing, storing, and distributing high-quality biological specimens, these repositories bridge the gap between discovery science and clinical application. Moreover, the integration of robust data management systems with physical sample archives has elevated biobanks from mere storage facilities to dynamic research enablers, fostering collaborations across academia, industry, and healthcare institutions.

As demand for precision diagnostics and targeted therapies intensifies, biobanks have embraced rigorous quality control measures, standardized protocols, and ethical governance frameworks. This ensures that researchers access well-characterized, consented specimens, thereby accelerating biomarker identification and drug development processes. Additionally, strategic alignment with regulatory agencies and adherence to international best practices have reinforced trust among stakeholders, paving the way for large-scale, multi-center studies that can yield statistically significant findings.

Looking ahead, biobanks will continue to evolve through technological adoption and network expansion, further reducing barriers to entry for research teams worldwide. The ability to harmonize genomic, proteomic, and clinical data with diverse sample types positions biobanks at the forefront of biomedical innovation. This introduction lays the groundwork for exploring transformative shifts, policy impacts, and strategic imperatives that define the contemporary biobank landscape.

Exploring the Major Paradigm Shifts Revolutionizing Biobank Operations Through Technological Advancements Data Integration and Collaborative Ecosystems

The biobank landscape has undergone seismic transformations driven by technological breakthroughs and shifting collaboration models. High-throughput genomic sequencing platforms now enable rapid analysis of thousands of samples in parallel, unlocking novel insights into disease mechanisms and patient stratification. Concurrently, the implementation of artificial intelligence and machine learning algorithms has revolutionized data curation and pattern recognition, enhancing predictive analytics and biomarker discovery at unprecedented speeds.

Digital biobank platforms have emerged as critical hubs, seamlessly connecting disparate sample repositories and enabling remote access to specimen metadata and analytic tools. Blockchain-based solutions are also gaining traction, offering immutable audit trails that bolster data integrity and consent management. These advancements have fostered a culture of open science, driving consortia-based research initiatives that draw on heterogeneous sample collections across geographical and institutional boundaries.

Moreover, the rise of virtual biobanks has reduced reliance on physical specimen transfers, as in silico data sharing becomes more prevalent. Collaborative ecosystems now span public-private partnerships, clinical networks, and patient advocacy groups, each contributing to rich multi-omics datasets. These paradigm shifts are redefining biobank value propositions, positioning them as strategic assets capable of propelling next-generation therapies and population health studies.

Assessing the Far-Reaching Consequences of United States 2025 Tariff Policies on Biobank Supply Chains Innovation Costs and Global Collaborations

The implementation of United States tariff policies in 2025 has introduced complex challenges for biobank operations that rely on intricate global supply chains. Heightened duties on laboratory consumables, cryogenic storage systems, and precision equipment have spurred cost inflation and procurement delays. As a result, biobank managers are reassessing vendor contracts, seeking alternative sourcing strategies, and exploring near-shoring opportunities to mitigate exposure to escalating import levies.

Furthermore, tariff-driven price volatility has reverberated through service portfolios, affecting sample analysis, data management, and logistics. Contract laboratories and transport providers have had to adjust their pricing models, prompting end users to negotiate multi-year agreements that lock in favorable terms. In parallel, some biobanks have intensified efforts to localize manufacturing of critical supplies, forging joint ventures with domestic producers to ensure continuity of operations and foster supply chain resilience.

To navigate this evolving landscape, industry stakeholders are engaging with trade associations and government bodies to seek clarifications, exemptions, and renegotiation of tariff schedules. Enhanced transparency in procurement planning and collaborative risk-sharing arrangements have emerged as essential components of strategic mitigation frameworks. By proactively addressing these tariff impacts, biobanks can preserve cost structures, maintain service quality, and sustain momentum in research and development endeavors.

Analyzing Critical Segmentation Dimensions Illuminating Diverse Biobank Types Components Sample Types Applications and End User Dynamics Driving Market Nuances

A nuanced understanding of market segmentation underpins targeted strategy development, as biobanks cater to diverse research, clinical, and commercial end users. The disease-oriented model focuses on specimens linked to specific pathologies, providing tailored resources for oncology, cardiology, and neurology studies. Conversely, genomic-based repositories curate DNA and RNA extracts to support population genomics and variant discovery efforts, while population-based collections gather samples across demographic cohorts to enable epidemiological research. Virtual biobanks consolidate metadata records into accessible digital libraries, effectively democratizing sample discovery without physical transfers.

Components of the biobanking ecosystem encompass consumables, specialized equipment, and a broad spectrum of services. Consumables such as reagents and storage vials are indispensable for daily operations, whereas equipment investments span incubators, centrifuges, and monitoring systems. The critical temperature control infrastructure integrates cryogenic storage systems, freezers, refrigerators, and thawing equipment to preserve sample integrity. Services extend from data management platforms and high-throughput sample analysis to storage, processing workflows and secure transport solutions tailored to sensitive biomaterials.

Sample types range from blood derivatives and cell lines to nucleic acids and tissue specimens, each demanding bespoke handling protocols. Applications traverse clinical diagnostics, personalized medicine initiatives, foundational research projects, and therapeutics development, including drug discovery pipelines and cutting-edge gene editing programs. End users such as academic institutions, biotechnology ventures, healthcare providers and pharmaceutical companies leverage biobanks to accelerate innovation. By dissecting these segmentation layers, stakeholders can craft offerings that align precisely with evolving research imperatives and commercial objectives.

Understanding the Distinct Regional Dynamics and Strategic Opportunities Across Americas Europe Middle East Africa and Asia Pacific Biobank Ecosystems

Regional dynamics profoundly influence the strategic trajectory of biobank initiatives, as geopolitical factors, funding landscapes and regulatory frameworks vary across territories. In the Americas, robust investment from public and private sectors has cultivated a mature ecosystem, characterized by well-established repositories integrated with leading academic medical centers and innovative biotech clusters. Regulatory oversight ensures patient consent and data privacy standards, while cross-border collaborations within North and South America facilitate large cohort studies.

In Europe, the Middle East, and Africa, harmonization of regulatory requirements under pan-European directives has enabled seamless sample exchanges and joint research consortia. Public funding programs and philanthropic foundations continue to underwrite comprehensive biobank networks, spanning national initiatives and disease-specific platforms. Emerging centers in North Africa and the Gulf region are also driving capacity building, often in partnership with established European counterparts.

The Asia-Pacific region is witnessing exponential growth, fueled by government-led precision medicine agendas and substantial investments in biotech infrastructure. Nations with large population bases are prioritizing biobank development to support public health surveillance, translational research and commercial R&D ventures. Strategic alliances between local research institutes and international technology providers are laying the groundwork for sustainable biobanking operations that can serve both domestic and global scientific communities.

Identifying Leading Industry Players Strategic Collaborations and Competitive Differentiators Shaping the Future Trajectory of the Biobank Market Landscape

Leading players in the biobank sector are differentiating through strategic partnerships, technological innovation and expanded service portfolios. Premier life sciences companies are leveraging their global distribution networks to offer turnkey biobanking solutions that integrate sample management software, cold chain logistics and customizable analytic workflows. Meanwhile, specialized service providers are forging alliances with academic medical centers to co-develop disease-focused repositories and accelerate translational research outputs.

Collaborations between equipment manufacturers and software developers have yielded integrated platforms that streamline operations from sample accessioning to data visualization. This convergence of hardware and digital solutions is enabling end users to optimize throughput, reduce manual error, and comply with stringent quality guidelines. Additionally, select market entrants are pursuing vertical integration, establishing in-house sequencing and bioinformatics capabilities that complement traditional storage and processing services.

Competitive differentiation is increasingly driven by value-added offerings such as advanced multi-omics profiling, secure remote access portals, and robust regulatory support. Companies that demonstrate proficiency in navigating complex compliance environments, while delivering scalable solutions, are gaining traction among pharmaceutical sponsors and research consortia. By continuously refining their ecosystems of services and technology, these leaders are setting new benchmarks for operational excellence and customer engagement.

Crafting Strategic Imperatives for Biobank Leaders to Navigate Regulatory Complexities Embrace Innovation and Strengthen Global Partnerships for Sustainable Growth

To thrive in an era of rapid innovation and regulatory complexity, biobank leaders must develop strategic roadmaps that balance agility with governance. Prioritizing investments in digital infrastructure will enable real-time tracking of sample provenance, automated quality control checks, and seamless integration with external data sources. Concurrently, diversifying supply chains through multi-vendor sourcing and regional partnerships can mitigate risks associated with trade policies and logistical disruptions.

Cultivating collaborative alliances with research institutions, patient advocacy groups and technology providers is essential for expanding specimen diversity and fostering translational breakthroughs. By co-investing in shared platforms and standardizing protocols, stakeholders can unlock economies of scale and accelerate study timelines. Equally important is the establishment of robust governance frameworks that address consent management, ethical use, and data privacy, thereby reinforcing stakeholder trust.

Finally, enhancing workforce capabilities through continuous training in bioinformatics, regulatory affairs and quality management will ensure that biobank teams remain at the cutting edge of best practices. Leaders should also explore public-private partnerships to leverage grant funding, tax incentives, and infrastructure support. By implementing these actionable measures, organizations can solidify their competitive positioning and drive long-term value for researchers and end users alike.

Detailing Rigorous Research Frameworks Data Collection Techniques and Analytical Approaches Underpinning Comprehensive Biobank Market Intelligence

The research methodology underpinning this comprehensive analysis combined multiple data collection techniques and analytical approaches to ensure depth and reliability. Primary insights were garnered through structured interviews with senior executives, scientific directors and procurement managers across leading biobank operations. These firsthand perspectives provided context on operational challenges, technology adoption trends and strategic priorities.

Secondary research encompassed a systematic review of scientific literature, patent filings, regulatory guidelines, and industry white papers. This review was augmented by data extraction from reputable public sources, enabling cross-validation of key developments in supply chains, tariff impacts, and collaborative frameworks. In addition, proprietary databases were consulted to map the competitive landscape and identify emerging service providers.

Data triangulation and thematic coding were applied to synthesize qualitative inputs with quantitative observations, producing cohesive insights that reflect market realities. A multi-stage validation process involved expert panel reviews and iterative feedback loops, ensuring that findings accurately represent the current biobank ecosystem. This rigorous methodology underlies the strategic analyses presented in this executive summary.

Synthesizing Key Insights and Strategic Takeaways to Empower Decision Makers in Steering Biobank Initiatives Toward Long Term Success and Impact

In summary, biobanks have ascended to a position of strategic importance within the biomedical research and healthcare innovation continuum. Technological advances in genomics, data analytics, and digital integration are reshaping operational paradigms, while tariff policies and supply chain considerations introduce new layers of complexity that demand proactive management. Nuanced segmentation insights reveal the diverse demands of disease-oriented, genomic-based, population and virtual repositories, each supported by specialized components and service offerings.

Regional dynamics underscore the need for tailored strategies that account for distinct regulatory frameworks, funding mechanisms, and collaborative ecosystems across the Americas, EMEA and Asia-Pacific. Leading companies are differentiating through holistic solution sets, strategic alliances and value-added services that encompass multi-omics profiling and advanced bioinformatics. To capitalize on these trends, biobank leaders must embrace digital transformation, diversify supply chains, and reinforce governance to maintain trust and compliance.

By synthesizing these insights, decision makers can chart a course toward sustainable growth, operational excellence and accelerated discovery. This executive summary provides the strategic foundation needed to navigate a rapidly evolving biobank landscape with confidence and clarity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing demand for personalized medicine fueling expansion of biobank facilities worldwide
  • 5.2. Integration of artificial intelligence and big data analytics in improving biobank sample processing
  • 5.3. Increasing government grants and funding initiatives boosting biobanking research capabilities
  • 5.4. Expansion of large-scale population-based and disease-specific biobanks for diverse medical studies
  • 5.5. Adoption of automated storage and retrieval technologies enhancing biobank operational efficiency
  • 5.6. Advancements in cryopreservation techniques improving long-term biospecimen quality and stability
  • 5.7. Strategic partnerships and collaborations between biobanks and pharmaceutical companies accelerating drug discovery
  • 5.8. Addressing ethical challenges and data privacy concerns shaping modern biobank governance frameworks
  • 5.9. Growing importance of biobanks in rare and complex disease research for better diagnostic solutions
  • 5.10. Emergence of commercial biobanks providing global access to high-quality biological samples for research

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Biobanks Market, by Type

  • 8.1. Introduction
  • 8.2. Disease-Oriented Biobanks
  • 8.3. Genomic-Based Biobanks
  • 8.4. Population-Based Biobanks
  • 8.5. Virtual Biobanks

9. Biobanks Market, by Component

  • 9.1. Introduction
  • 9.2. Consumables
  • 9.3. Equipment
    • 9.3.1. Incubators & Centrifuges
    • 9.3.2. Monitoring Systems
    • 9.3.3. Temperature Control Systems
      • 9.3.3.1. Cryogenic Storage Systems
      • 9.3.3.2. Freezers & Refrigerators
      • 9.3.3.3. Thawing Equipment
  • 9.4. Services
    • 9.4.1. Data Management
    • 9.4.2. Sample Analysis
    • 9.4.3. Storage & Processing
    • 9.4.4. Transport

10. Biobanks Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood Derivatives
  • 10.3. Cell Lines
  • 10.4. Nucleic Acid
  • 10.5. Tissues

11. Biobanks Market, by Application

  • 11.1. Introduction
  • 11.2. Clinical Diagnostics
  • 11.3. Personalized Medicine
  • 11.4. Research
  • 11.5. Therapeutics
    • 11.5.1. Drug Development
    • 11.5.2. Gene Editing

12. Biobanks Market, by End User

  • 12.1. Introduction
  • 12.2. Academic Institutions
  • 12.3. Biotechnology Companies
  • 12.4. Hospitals
  • 12.5. Pharmaceutical Companies

13. Americas Biobanks Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Biobanks Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Biobanks Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. ASKION GmbH
    • 16.3.2. Avantor, Inc.
    • 16.3.3. Bay Biosciences LLC
    • 16.3.4. Beckman Coulter, Inc. by Danaher Corporation
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. BioIVT LLC
    • 16.3.7. BioKryo by L'AIR LIQUIDE S.A.
    • 16.3.8. BioLife Solutions Inc.
    • 16.3.9. BocaBio
    • 16.3.10. Charles River Laboratories International, Inc.
    • 16.3.11. Cryoport Systems, LLC
    • 16.3.12. CTIBiotech
    • 16.3.13. Cureline, Inc.
    • 16.3.14. Firalis Group
    • 16.3.15. Greiner AG
    • 16.3.16. Hamilton Company
    • 16.3.17. LVL Technologies GmbH & Co. KG
    • 16.3.18. Merck KGaA
    • 16.3.19. Micronic Holding B.V.
    • 16.3.20. ProteoGenex, Inc.
    • 16.3.21. Provia Laboratories, LLC
    • 16.3.22. Qiagen N.V.
    • 16.3.23. Shanghai Outdo Biotech Co. Ltd
    • 16.3.24. Taylor-Wharton
    • 16.3.25. Tecan Trading AG
    • 16.3.26. Thermo Fisher Scientific Inc.
    • 16.3.27. UK Biobank Limited

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. BIOBANKS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. BIOBANKS MARKET: RESEARCHAI
  • FIGURE 26. BIOBANKS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. BIOBANKS MARKET: RESEARCHCONTACTS
  • FIGURE 28. BIOBANKS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOBANKS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOBANKS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. ITALY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 301. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 303. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 309. ITALY BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 311. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 315. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 317. SPAIN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 319. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 321. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 326. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 327. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 337. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 345. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 350. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 352. SAUDI ARABIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 354. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 356. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 357. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 358. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 359. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 360. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 361. SAUDI ARABIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 362. SAUDI ARABIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 363. SAUDI ARABIA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 364. SAUDI ARABIA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 365. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 366. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 367. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 368. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 369. SOUTH AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 370. SOUTH AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 371. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 372. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 373. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 374. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 375. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 376. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 377. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 378. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 379. SOUTH AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 380. SOUTH AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 381. SOUTH AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 382. SOUTH AFRICA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 383. DENMARK BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 384. DENMARK BIOBANKS MARKET SIZE, BY TYPE, 2025-20